Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

395
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
395
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

140
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
140
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

626
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
626
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

870
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
870
Inflammatory Response01:28

Inflammatory Response

15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Change in walking cadence as a digital outcome measure of clinically meaningful improvement in gait speed and 6-minute walk test distance after a mobility intervention in older adults.

PloS one·2026
Same author

Psychometric properties of the Pittsburgh Fatigability Scale for assessing physical and mental fatigability in Brazilian older adults (PFS-Brasil).

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2026
Same author

MicroRNA Regulatory Targets Related to VO<sub>2</sub>peak Decline in Older Adult Participants of the Study of Muscle, Mobility and Aging (SOMMA).

bioRxiv : the preprint server for biology·2026
Same author

Prospective links between childhood family income and subclinical atherosclerosis in a sample of young men.

Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2026
Same author

S-Equol as a Gut-Derived Phytoestrogen Targeting Estrogen Receptor β: A Promising Bioactive Nutrient for Bone Health in Aging Women and Men: A Narrative Review.

Nutrients·2025
Same author

The COVID-19 Pandemic and Acute Coronary Syndrome Admissions and Deaths in Allegheny County, Pennsylvania.

Healthcare (Basel, Switzerland)·2025

相关实验视频

Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

"减少炎症促进更大的健康试验 (右) "研究概念,理由和设计.

Sebastian E Sattui1, Marnie Bertolet2, Daniel E Forman1,3,4

  • 1Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Journal of the American Geriatrics Society
|January 10, 2026
PubMed
概括
此摘要是机器生成的。

该RIGHT研究的目的是调查一种介素-6 (IL-6) 抑制剂clazkizumab是否能改善老年人的身体和认知功能. 这项试验旨在减缓与年龄相关的衰退,并评估老年科学假设.

关键词:
老化的老化 衰老的老化临床试验临床试验临床试验临床试验临床试验这是一种炎症炎症炎症炎症.

更多相关视频

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

12.1K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

801

相关实验视频

Last Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

12.1K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

801

科学领域:

  • 老年学和衰老研究研究.
  • 免疫学和炎症 免疫学和炎症
  • 临床试验和治疗方法

背景情况:

  • 衰老与慢性低度炎症 (炎症) 相关,与功能衰退有关.
  • 介乐-6 (IL-6) 是一种关键的促炎性细胞因子,涉及与年龄相关的疾病和功能障碍.
  • 向IL-6可能提供一种治疗策略,以减轻与衰老相关的功能衰退.

研究的目的:

  • 评估IL-6抑制剂clazkizumab在改善或减缓老年人身体,认知和血管功能下降方面的疗效.
  • 测试老年科学假设,即干预衰老过程可以导致广泛的健康改善.
  • 评估clazkizumab在这个人群中的安全性和耐受性.

主要方法:

  • 一个单中心,随机,双盲,安慰剂对照试验 (RIGHT研究).
  • 招募年龄≥70岁的参与者,身体功能低至中等,IL-6水平升高.
  • 用clazkizumab治疗 (每4周注射5毫克皮下每24周) 或安慰剂,以步行速度为主要结果.

主要成果:

  • 主要结局:在24周内400米步行速度的变化.
  • 二次结果:评估身体功能 (SPPB,氧气消耗,疲劳),认知功能,血管健康,炎症标志物 (IL-6,CRP) 和安全.
  • 探索6个月的移动性变化和其他健康方面.

结论:

  • 这项RIGHT研究将提供关于IL-6抑制对抗与年龄有关的功能衰退的潜力的关键数据.
  • 结果将告知针对健康寿命延长的衰老机制的有效性.
  • 该研究将确定clazkizumab在老年成人队列中的安全性和有效性.